Aqueous Pharma has received European Union approval for its three layered artificial tear formula for dry eye, FreshKote.
Aqueous Pharma has received European Union approval for its three layered artificial tear formula for dry eye, FreshKote.
The approval comes after the formula was granted the CE Mark. FreshKote is now approved for sale in all 25 countries of the EU and was also recently launched in the United States.
The FreshKote formula is patent pending.
COPHy 2023: Restorative therapies and the path to them
March 24th 2023In a keynote lecture at the 14th Annual Congress on Controversies in Ophthalmology in Lisbon, Hendrik Scholl, MD, co-founder and director of the Institute of Molecular and Clinical Ophthalmology Basel, discussed its mission to unravel the mysteries of vision and human eye disease.
2 Clarke Drive
Cranbury, NJ 08512